Okayama N - Search Results

1

FcγR and EGFR polymorphisms as predictive markers of cetuximab efficacy in metastatic colorectal cancer.

Inoue Y, Hazama S, Iwamoto S, Miyake Y, Matsuda C, Tsunedomi R, Okayama N, Hinoda Y, Yamasaki T, Suehiro Y, Yoshino S, Sakamoto J, Mishima H, Oka M. Inoue Y, et al. Among authors: okayama n. Mol Diagn Ther. 2014 Oct;18(5):541-8. doi: 10.1007/s40291-014-0103-6. Mol Diagn Ther. 2014. PMID: 24828248

2

Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1*28 polymorphism.

Hazama S, Nagashima A, Kondo H, Yoshida S, Shimizu R, Araki A, Yoshino S, Okayama N, Hinoda Y, Oka M. Hazama S, et al. Among authors: okayama n. Cancer Sci. 2010 Mar;101(3):722-7. doi: 10.1111/j.1349-7006.2009.01428.x. Epub 2009 Nov 7. Cancer Sci. 2010. PMID: 20028383 Free article. Clinical Trial.

3

UDP-glucuronosyltransferase (UGT) 1A1*28 polymorphism-directed phase II study of irinotecan with 5'-deoxy-5-fluorouridine (5'-DFUR) for metastatic colorectal cancer.

Kanekiyo S, Hazama S, Kondo H, Nagashima A, Eto R, Yoshida S, Shimizu R, Araki A, Yamamoto T, Uchiyama T, Yoshino S, Okayama N, Hinoda Y, Oka M. Kanekiyo S, et al. Among authors: okayama n. Anticancer Res. 2013 Aug;33(8):3423-30. Anticancer Res. 2013. PMID: 23898114 Clinical Trial.

4

UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan.

Hazama S, Mishima H, Tsunedomi R, Okuyama Y, Kato T, Takahashi K, Nozawa H, Ando H, Kobayashi M, Takemoto H, Nagata N, Kanekiyo S, Inoue Y, Hamamoto Y, Fujita Y, Hinoda Y, Okayama N, Oba K, Sakamoto J, Oka M. Hazama S, et al. Among authors: okayama n. Cancer Sci. 2013 Dec;104(12):1662-9. doi: 10.1111/cas.12283. Epub 2013 Oct 27. Cancer Sci. 2013. PMID: 24033692 Free PMC article. Clinical Trial.

5

A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypes.

Tsunedomi R, Hazama S, Fujita Y, Okayama N, Kanekiyo S, Inoue Y, Yoshino S, Yamasaki T, Suehiro Y, Oba K, Mishima H, Sakamoto J, Hamamoto Y, Oka M. Tsunedomi R, et al. Among authors: okayama n. Int J Oncol. 2014 Oct;45(4):1381-90. doi: 10.3892/ijo.2014.2556. Epub 2014 Jul 22. Int J Oncol. 2014. PMID: 25175642 Free PMC article.

6

Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer.

Hinoda Y, Okayama N, Takano N, Fujimura K, Suehiro Y, Hamanaka Y, Hazama S, Kitamura Y, Kamatani N, Oka M. Hinoda Y, et al. Among authors: okayama n. Int J Cancer. 2002 Dec 10;102(5):526-9. doi: 10.1002/ijc.10750. Int J Cancer. 2002. PMID: 12432557 Free article.

7

Relation between cytokine promoter gene polymorphism and toxicity of 5-fluorouracil plus cisplatin chemotherapy.

Sakamoto K, Oka M, Yoshino S, Hazama S, Abe T, Okayama N, Hinoda Y. Sakamoto K, et al. Among authors: okayama n. Oncol Rep. 2006 Aug;16(2):381-7. Oncol Rep. 2006. PMID: 16820919

8

Determination of ancestral allele for possible human cancer-associated polymorphisms.

Maruta Y, Okayama N, Hiura M, Suehiro Y, Hirai H, Hinoda Y. Maruta Y, et al. Among authors: okayama n. Cancer Genet Cytogenet. 2008 Jan 1;180(1):24-9. doi: 10.1016/j.cancergencyto.2007.09.011. Cancer Genet Cytogenet. 2008. PMID: 18068529

9

TWIST1 hypermethylation is observed frequently in colorectal tumors and its overexpression is associated with unfavorable outcomes in patients with colorectal cancer.

Okada T, Suehiro Y, Ueno K, Mitomori S, Kaneko S, Nishioka M, Okayama N, Sakai K, Higaki S, Hazama S, Hirata H, Sakaida I, Oka M, Hinoda Y. Okada T, et al. Among authors: okayama n. Genes Chromosomes Cancer. 2010 May;49(5):452-62. doi: 10.1002/gcc.20755. Genes Chromosomes Cancer. 2010. PMID: 20140954

10

The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues.

Okayama N, Nishioka M, Hazama S, Sakai K, Suehiro Y, Maekawa M, Sakamoto J, Iwamoto S, Kato T, Mishima H, Oka M, Hinoda Y. Okayama N, et al. Jpn J Clin Oncol. 2011 Feb;41(2):165-71. doi: 10.1093/jjco/hyq173. Epub 2010 Oct 5. Jpn J Clin Oncol. 2011. PMID: 20926413

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

148 results

Search Page